Antibody Drug Discovery:
From Target Validation to Candidate Selection
About this webinar
This webinar will provide an overview of the antibody discovery process highlighting the critical steps involved in developing effective antibody-based therapeutics. The goal is to guide the audience through the different stages of antibody drug discovery, shedding light on the latest advancements, methodologies and challenges encountered along the way. In addition, the webinar will cover Benchling’s Antibody Solution Accelerator, a set of ready-to-use configurations necessary to capture the process of drug discovery.
Throughout the webinar, attendees will gain valuable insights into how Benchling’s Antibody Solution Accelerator supports the critical elements of antibody discovery, ensuring a more streamlined and successful drug development process. Register now to learn best practices for target identification, screening, lead selection and in vivo safety and efficacy.
Who should attend
- Research Scientists
- Research Associates
- Research Executives
What you will learn
- Target Identification: The crucial step of identifying and validating specific molecular targets that play a role in disease pathogenesis
- Screening: Methods to identify potential antibody candidates
- Lead Selection: Criteria and assays used to assess factors such as binding affinity, specificity, stability and pharmacokinetic properties to choose the most suitable leads for further development
- In Vivo Safety & Efficacy: Assessing the performance of the antibody in mice and other model organisms
Featured Speakers
Vega Shah, PhD
Vega Shah is an experienced biologist and former research scientist. In her current role, she helps biotech companies use software to accelerate their research. She was previously a product manager for an electronic lab notebook for biologics and screening. Prior to her industry career, she was a scientific researcher at Lawrence Berkeley National Lab, University of Washington and UC Berkeley.
Sanjay Saraf
Sanjay Saraf is a Product Manager at Benchling, where he helps biotech companies solve data analysis, automation, and preclinical research problems. He is now focused on Studies, a product which enables scientists to capture accurate, intelligent and connected in vivo study data. Prior to Benchling, Sanjay led healthcare and biology partnerships at Palantir Technologies, focusing on pharma, government and clinical organizations.
Partner for this event
Benchling
Benchling is a cloud-based platform for biotechnology research and development. Benchling helps scientists accelerate the full R&D lifecycle with our R&D Cloud, which consists of data, collaboration, and insights built on a trusted and open platform.